(Q44371465)

2 December 2017

Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy (English)

1 reference

2 December 2017

Ying Hong

1

1 reference

2 December 2017

Sarah S C Hui

series ordinal

2

1 reference

2 December 2017

Benjamin T Y Chan

series ordinal

3

1 reference

2 December 2017

Jiayu Hou

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

2 December 2017

1 reference

2 December 2017

72

1 reference

2 December 2017

22

1 reference

2 December 2017

2499-2507

1 reference

Cellular mechanisms of cardiac hypertrophy

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

Involvement of multiple cis elements in basal- and alpha-adrenergic agonist-inducible atrial natriuretic factor transcription. Roles for serum response elements and an SP-1-like element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

Cardiac hypertrophy. Mechanical, neural, and endocrine dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

Adrenergic regulation of the skeletal alpha-actin gene promoter during myocardial cell hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

The cellular actions of beta-adrenergic receptor agonists: looking beyond cAMP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

Catecholamine metabolism inhibitors and receptor blockades only partially suppress cardiac hypertrophy of juvenile visceral steatosis mice with systemic carnitine deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

Alterations in cardiac adrenergic terminal function and beta-adrenoceptor density in pacing-induced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

Cardiac sympathetic nerve function in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

MYOCARDIAL NOREPINEPHRINE CONCENTRATION IN MAN. EFFECTS OF RESERPINE AND OF CONGESTIVE HEART FAILURE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

Norepinephrine turnover in peripheral tissues of rats with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900144-9

10.1016/S0024-3205(03)00144-9

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference